Lazard Transactions


DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided

Clear all Clear

Download results

Showing 1 to 10 of 1318 Results

May 19, 2026
France

Lazard acted as Financial Advisor to DomusVi on its €500m inaugural bond issuance, €1,500m TLB refinancing and EUR289m RCF refinancing and upsize

$2.6 Billion

May 19, 2026
Netherlands

KNDS ANNOUNCES THE SUCCESSFUL SALE OF RENK SHARES

$304.9 Million

May 12, 2026
France

Lazard acted as financial advisor to Atos on the successful pricing of its €1,250m Senior Secured Fixed and Floating Notes offering and the signing of its new €110m revolving credit facility.

$1.6 Billion

May 11, 2026
Norway

Verdane closes €635 million continuation vehicle anchored by Arrive Group, alongside Talentech and Pet Media Group, with Coller as sole lead investor

$748.2 Million

April 27, 2026
Germany

Novem Group S.A. extends existing €210m syndicated loan facility

$246 Million

April 23, 2026
France

Isabel Marant Successfully Completed a Consent Solicitation Relating to its €265,000,000 8.000% Senior Secured Notes, Extending Maturity to September 1, 2030

$310.8 Million

April 17, 2026
France

Lazard acted as Financial Advisor to Loxam on its new and upsized €500m RCF to bolster liquidity and growth

$588.2 Million

March 30, 2026
United Kingdom

Lazard advises Fremman Capital on a continuation fund for Kids Planet

Undisclosed

March 20, 2026
United States

Falfurrias Launches Crosslakes Next Growth Phase Through Single-Asset Continuation Fund Led by Leonard Green & Partners

Undisclosed

March 16, 2026
United Kingdom, United States

Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its MultiProduct Specialty Commercial Platform

$1.3 Billion